{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T07:28:55Z","timestamp":1784618935086,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.clml.2022.02.004","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T03:16:09Z","timestamp":1645672569000},"page":"e541-e548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinicopathological Factors Associated with the Prognosis and Chronicity of Lymphomatoid Papulosis: A Retrospective Cohort Study"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3432-8306","authenticated-orcid":false,"given":"Joon Min","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Hyun","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Eun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Sik","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2022.02.004_bib0001","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clml.2022.02.004_bib0002","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archderm.1968.01610070029004","article-title":"Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign\u2014Histologically malignant","volume":"97","author":"Macaulay","year":"1968","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clml.2022.02.004_bib0003","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1182\/blood-2011-05-351346","article-title":"EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"118","author":"Kempf","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2022.02.004_bib0004","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2133.1982.tb00331.x","article-title":"The clinical and histological spectrum of lymphomatoid papulosis","volume":"107","author":"Willemze","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clml.2022.02.004_bib0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0190-9622(83)70011-3","article-title":"The clinicopathologic spectrum of lymphomatoid papulosis: study of 31 cases","volume":"8","author":"Sanchez","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clml.2022.02.004_bib0006","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/PAS.0b013e3181e75356","article-title":"A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases","volume":"34","author":"Saggini","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2022.02.004_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0b013e3182648596","article-title":"Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas","volume":"37","author":"Kempf","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2022.02.004_bib0008","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0b013e318282d01e","article-title":"Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis","volume":"37","author":"Karai","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clml.2022.02.004_bib0009","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30+ lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.clml.2022.02.004_bib0010","first-page":"630","article-title":"Lymphomatoid papulosis in association with mycosis fungoides: a study of 15 cases","volume":"139","author":"Basarab","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clml.2022.02.004_bib0011","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0190-9622(87)70045-0","article-title":"Lymphomatoid papulosis following Hodgkin's disease","volume":"16","author":"Lederman","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clml.2022.02.004_bib0012","first-page":"1158","article-title":"Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders","volume":"23","author":"Kadin","year":"2009","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.clml.2022.02.004_bib0013","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jaad.2011.07.012","article-title":"In search of prognostic indicators for lymphomatoid papulosis: a retrospective study of 123 patients","volume":"66","author":"de Souza","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clml.2022.02.004_bib0014","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaad.2015.09.013","article-title":"Lymphomatoid papulosis: treatment response and associated lymphomas in a study of 180 patients","volume":"74","author":"Wieser","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clml.2022.02.004_bib0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1634\/theoncologist.2015-0242","article-title":"Frequency and risk factors for associated lymphomas in patients with lymphomatoid papulosis","volume":"21","author":"Cordel","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.clml.2022.02.004_bib0016","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1365-2133.1992.tb00106.x","article-title":"The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas","volume":"126","author":"Beljaards","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clml.2022.02.004_bib0017","doi-asserted-by":"crossref","first-page":"24","DOI":"10.12788\/j.sder.2018.001","article-title":"Cutaneous CD30-positive T-cell lymphoproliferative disorders\u2014Clinical and histopathologic features, differential diagnosis, and treatment","volume":"37","author":"Kempf","year":"2018","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clml.2022.02.004_bib0018","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.clml.2022.02.004_bib0019","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","volume":"110","author":"Kim","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clml.2022.02.004_bib0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00000372-199704000-00015","article-title":"Follicular lymphomatoid papulosis","volume":"19","author":"Kato","year":"1997","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clml.2022.02.004_bib0021","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jaad.2012.12.952","article-title":"Follicular lymphomatoid papulosis revisited: a study of 11 cases, with new histopathological findings","volume":"68","author":"Kempf","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clml.2022.02.004_bib0022","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/ced.13256","article-title":"First-line treatment in lymphomatoid papulosis: a retrospective multicentre study","volume":"43","author":"Fern\u00e1ndez-de-Misa","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clml.2022.02.004_bib0023","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/DAD.0b013e3182a64388","article-title":"CD30-negative lymphomatoid papulosis type D in an elderly man","volume":"36","author":"Cho-Vega","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clml.2022.02.004_bib0024","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/ijd.14309","article-title":"CD 8-positive lymphomatoid papulosis (type D): some lesions may lack CD 30 expression and overlap histologically with mycosis fungoides","volume":"58","author":"Simo","year":"2019","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clml.2022.02.004_bib0025","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/cup.13974","article-title":"A case of lymphomatoid papulosis type E in a young adult: an uncommon entity","volume":"48","author":"Rajashekara Swamy","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clml.2022.02.004_bib0026","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/ced.14730","article-title":"Lymphomatoid papulosis types D and E: a multicentre series of the French cutaneous lymphomas study group","volume":"46","author":"Bergqvist","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clml.2022.02.004_bib0027","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0190-9622(94)70019-2","article-title":"Lymphomatoid papulosis: a clinical and histopathologic review of 53 cases with leukocyte immunophenotyping, DNA flow cytometry, and T-cell receptor gene rearrangement studies","volume":"30","author":"el-Azhary","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clml.2022.02.004_bib0028","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1056\/NEJM198608213150802","article-title":"Clonal T-cell populations in lymphomatoid papulosis. Evidence of a lymphoproliferative origin for a clinically benign disease","volume":"315","author":"Weiss","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clml.2022.02.004_bib0029","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3109\/10428194.2014.958821","article-title":"Association of clinicopathological characteristics with secondary neoplastic lymphoproliferative disorders in patients with lymphomatoid papulosis","volume":"56","author":"Nikolaou","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2022.02.004_bib0030","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/1203475417716366","article-title":"Associated hematolymphoid malignancies in patients with lymphomatoid papulosis: a Canadian retrospective study","volume":"21","author":"AbuHilal","year":"2017","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clml.2022.02.004_bib0031","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood.V94.8.2854.420k07_2854_2861","article-title":"A deletion in the gene for transforming growth factor \u03b2 type I receptor abolishes growth regulation by transforming growth factor \u03b2 in a cutaneous T-cell lymphoma","volume":"94","author":"Schiemann","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.clml.2022.02.004_bib0032","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1182\/blood.V94.9.3077","article-title":"CD30-CD30 ligand interaction in primary cutaneous CD30+ T-cell lymphomas: a clue to the pathophysiology of clinical regression","volume":"94","author":"Mori","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.clml.2022.02.004_bib0033","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archderm.143.9.1144","article-title":"Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases","volume":"143","author":"Grange","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clml.2022.02.004_bib0034","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jaad.2015.12.053","article-title":"Cutaneous anaplastic large-cell lymphoma (ALCL): a comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site","volume":"74","author":"Lee","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clml.2022.02.004_bib0035","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/1346-8138.15972","article-title":"Clinicopathological and prognostic study of primary cutaneous extranodal natural killer\/T-cell lymphoma, nasal type: a systematic review","volume":"48","author":"Jung","year":"2021","journal-title":"J Dermatol"},{"key":"10.1016\/j.clml.2022.02.004_bib0036","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1346-8138.2010.01150.x","article-title":"Primary cutaneous anaplastic large cell lymphoma with leg involvement: a case report and review of 11 cases","volume":"38","author":"Sugaya","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.clml.2022.02.004_bib0037","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0b013e318282d01e","article-title":"Chromosomal rearrangements of 6p25. 3 define a new subtype of lymphomatoid papulosis","volume":"37","author":"Karai","year":"2013","journal-title":"Am J Surg Pathol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265022000623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265022000623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T13:59:55Z","timestamp":1682949595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265022000623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2152265022000623"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2022.02.004","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological Factors Associated with the Prognosis and Chronicity of Lymphomatoid Papulosis: A Retrospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2022.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}